Company Filing History:
Years Active: 2007-2009
Title: Innovations in Cancer Treatment by Joe Corvera
Introduction
Joe Corvera is an accomplished inventor based in Baltimore, MD (US), known for his significant contributions to cancer research and treatment. With a total of 2 patents, he has focused on developing novel monoclonal antibodies that target specific types of cancer, including breast, lung, and colon cancer. His work aims to improve diagnosis, prognosis, and treatment options for patients suffering from these diseases.
Latest Patents
Corvera's latest patents include groundbreaking advancements in cancer-specific monoclonal antibodies. One of his notable inventions is a novel monoclonal antibody that does not bind to the cell surface of normal human tissues, making it a promising candidate for targeted cancer therapy. This antibody is designed to recognize cancer-specific antigens with molecular weights ranging from 40-52 kDa to 130-200 kDa. The corresponding polynucleotides encoding these antigens and the CDR regions of the antibody are also disclosed. These innovations are crucial for the diagnosis, prognosis, and treatment of human breast cancer. Additionally, another patent features a monoclonal antibody, 7H11, which is reactive with human cancer and has similar properties, ensuring tumor specificity and utility in therapy, diagnosis, monitoring, detecting, and imaging of cancers.
Career Highlights
Joe Corvera is currently associated with A&G Pharmaceutical, Inc., where he continues to advance his research in cancer therapeutics. His work has garnered attention for its potential to revolutionize cancer treatment and improve patient outcomes.
Collaborations
Corvera collaborates with talented professionals in the field, including Le Sun and Ginette Serrero, to further enhance the impact of his research and innovations.
Conclusion
Joe Corvera's contributions to the field of cancer research through his innovative monoclonal antibodies represent a significant step forward in the fight against cancer. His work not only highlights the importance of targeted therapies but also showcases the potential for improved diagnostic and treatment methods for patients worldwide.